Celecoxib, a cyclooxygenase 2 inhibitor as a potential chemopreventive to UV-induced skin cancer: A study in the hairless mouse model

Archives of Dermatology

Volumn 138, Issue 6, 2002, Pages 751-755

  Orengo, Ida F ^a,b   Gerguis, Janette ^a,b   Phillips, Rhea ^a   Guevara, Adrian ^a   Lewis, Alan T ^a   Black, Homer S ^a,b  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b MICHAEL E DEBAKEY VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELECOXIB; CYCLOOXYGENASE 2 INHIBITOR; PROSTAGLANDIN E2;

ANIMAL EXPERIMENT; ANIMAL FOOD; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER PREVENTION; CHEMOPROPHYLAXIS; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE COURSE; DOSE RESPONSE; DRUG EFFICACY; DRUG MEGADOSE; EPIDERMIS; FEMALE; MOUSE; MULTIPLE CANCER; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; PROSTAGLANDIN BLOOD LEVEL; RADIATION CARCINOGENESIS; RANDOMIZATION; SKIN CANCER; TISSUE LEVEL; ULTRAVIOLET RADIATION;

EID: 0036279847     PISSN: 0003987X     EISSN: None     Source Type: Journal    
DOI: 10.1001/archderm.138.6.751     Document Type: Article

References (53)

1. Arachidonic acid oxygenation by COX-1 and COX-2: Mechanisms of catalysis and inhibition
2. 2 in human skin
3. Involvement of nuclear factor kappa B in the regulation of cyclooxygenase-2 expression by interleukin-1 in rhematoid synoviocytes
4. Evidence for involvement of NF-kappaB in the transcriptional control of COX-2 gene expression by IL-1beta
5. Tumor necrosis factor-alpha promotes sustained cyclooxygenase-2 expression attenuation by dexamethasone and NSAIDs
6. Molecular cloning of human prostaglandin endoperoxide synthase type II and demonstration of expression in response to cytokines
7. Upregulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas
8. 715 knockout mice by inhibition of cyclooxygenase 2 (COX-2)
9. Size- and invasion-dependent increase in cyclooxygenase 2 levels in human colorectal carcinomas
10. Differential expression and regulation of cyclooxygenase-1 and -2 in two human breast cancer cell lines
11. Expression of cyclooxygenase-1 and cyclooxygenase-2 in human breast cancer
12. Increased expression of cyclooxygenase 2 occurs frequently in human lung cancers, specifically in adenocarcinomas
13. Expression of cyclooxygenase-2 protein in gastric adenocarcinoma
14. Cyclooxygenase-2 overexpression enhances lymphatic invasion and metastasis in human gastric carcinoma
15. Cyclooxygenase-2 expression in human esophageal carcinoma
16. Cyclooxygenase-2 expression is upregulated in human pancreatic cancer
17. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs
18. Use of nonsteroidal anti-inflammatory drugs and incidence of colorectal cancer: A population-based study
19. Association between coronary heart disease and cancer of the breast, prostate, and colon
20. Low-dose aspirin and incidence of colorectal tumors in a randomized trial
21. Non-steroidal antiinflammatories and breast cancer
22. Adverse effects of nonsteroidal antiinflammatory drugs on the gastrointestinal system
23. Mechanism of non-steroidal anti-inflammatory drug (NSAID) induced gastrointestinal damage: Potential for development of gastrointestinal tract safe NSAIDs
24. Non-steroidal anti-inflammatory drugs and cyclooxygenase-2 selectivity in gastroenterology
25. A pilot endoscopic study of the gastroduodenal effects of SC-58635: A novel COX-2 selective inhibitor
26. An overview of skin cancers
27. Epidemiology of solar keratoses
28. Ultraviolet light as a carcinogen
29. Differential expression of prostaglandin H synthase isozymes during multistage carcinogenesis in mouse epidermis
30. COX-2 expression is induced by UVB exposure in human skin: Implication for the development of skin cancer
31. Lamp/filter systems for simulation of solar UV irradiance under reduced atmospheric ozone
32. Influence of omega-6, -3 fatty acid sources on the initiation and promotion stages of photocarcinogenesis
33. Relation of antioxidants and level of dietary lipid to epidermal lipid peroxidation and ultraviolet carcinogenesis
34. A method of bioassay of an epidermal chalone-like inhibitor
35. Role of prostaglandins in tumor promotion
36. Increased cyclooxygenase-2 levels in carcinogen-induced rat colonic tumors
37. Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2
38. Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis
39. Cyclooxygenase-2 gene expression in human breast cancer
40. Ibuprofen-induced inhibition of cyclooxygenase isoform gene expression and regression of rat mammary carcinomas
41. Growth arrest of DMBA-induced mammary carcinogenesis with ibuprofen treatment in female Sprague-Dawley rats
42. Photoprotective effect of topical anti-inflammatory agents against ultraviolet radiation-induced chronic skin damage in the hairless mouse
43. Inhibition of ultraviolet-B epidermal ornithine decarboxyalse induction and skin carcinogenesis in hairless mice by topical indomethacin and triancinolone acetonide
44. The protective effect of indomethacin on photocarcinogenesis in hairless mice
45. Effects of systemic indomethacin on photocarcinogenesis in hairless mice
46. Reduction of UV-induced skin tumors in hairless mice by selective COX-2 inhibition
47. Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor, and indomethacin against ultraviolet light-induced skin carcinogenesis
48. Modification of membrane composition, eicosanoid metabolism,and immunoresponsiveness by dietary omega-3 and omega-6 fatty acid sources, modulators of ultraviolet-carcinogenesis
49. Diet and skin cancer